Inovio Coronavirus Vaccine Candidate Trial Halted Due to FDA Inquiry
The regulator has a series of questions for the biotech's testing regime for INO-4800.
Full Article
Inovio Coronavirus Vaccine Candidate Trial Halted Due to FDA Inquiry
Motley Fool
0 shares
1 views
You might like
Related news coverage
Stock Alert: Inovio Pharma Plummets 30% As FDA Puts On Hold Its Coronavirus Vaccine
Shares of Inovio Pharmaceuticals, Inc. (INO) tanked 30% on Monday morning after the biotechnology company announced that phase 2/3..
RTTNews
Inovio stock plunges more than 34% as FDA puts Covid-19 vaccine trial on hold
Inovio Pharmaceutical Inc.'s stock price plunged more than 34% Monday morning after the Plymouth Meeting biotech company announced..
bizjournals